Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T18:09:37.201Z.
Calculation as of: 2026-10-06T18:09:37.201Z.
Quote observation: 2026-10-06T18:05:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 08fea6a2878daf509c4a2714b7418dcfec0265989d531cb4479ebc608e1bd708
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$285.37M
Price/OCF Ratio
N/A
TTM Avg
2.51
3Y Avg
2.51
5Y Avg
2.51
Market Cap
$285.63M
Price/OCF Ratio
N/A
TTM Avg
4132.33
3Y Avg
4132.33
5Y Avg
4132.33
Market Cap
$283.58M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$282.30M
Price/OCF Ratio
N/A
TTM Avg
55.15
3Y Avg
55.15
5Y Avg
55.15
Market Cap
$281.53M
Price/OCF Ratio
N/A
TTM Avg
108.55
3Y Avg
108.55
5Y Avg
108.55
Market Cap
$291.39M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sagimet Biosciences Inc. (SGMT) | $285.72M | N/A | N/A | N/A | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.37M | N/A | 2.51 | 2.51 | 2.51 |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.63M | N/A | 4132.33 | 4132.33 | 4132.33 |
| Standard BioTools Inc. (LAB)vs › | $286.67M | N/A | N/A | N/A | N/A |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $283.58M | N/A | N/A | N/A | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $282.30M | N/A | 55.15 | 55.15 | 55.15 |
| Aurora Cannabis Inc. (ACB)vs › | $281.53M | N/A | 108.55 | 108.55 | 108.55 |
| Larimar Therapeutics, Inc. (LRMR)vs › | $291.39M | N/A | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE)vs › | $271.58M | N/A | N/A | N/A | N/A |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $271.24M | N/A | N/A | N/A | N/A |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
